MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/mr/road074

Медицинская библиотека · Modern rheumatology · 2024

A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan.

Harigai Masayoshi, Miyamae Takako, Hashimoto Hideyuki, Umetsu Kosei, Yamashita Katsuhisa, Nakaoka Yoshikazu

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеКлиническое исследование IV фазыПеревод в очереди

Аннотация

OBJECTIVES

In clinical trials, tocilizumab (TCZ) is efficacious in patients with giant cell arteritis (GCA). This study evaluated the real-world tolerability and effectiveness of TCZ in Japanese patients with GCA.

METHODS

In this multicentre, prospective, Phase 4, large-scale, observational study, patients with GCA (with no TCZ treatment 6 months before the study) were recruited from 71 centres across Japan. Patients received subcutaneous TCZ 162 mg weekly (observation period, 52 weeks).

RESULTS

Of the 117 patients [female, 70.1%; mean age, 74.2 years; mean disease duration, 1.4 years; treated for new-onset GCA, 71.8%; presence of large-vessel lesions (LVLs), 61.5%; previous immunosuppressant use, 28.2%; glucocorticoids at baseline, 95.7% (mean: 22.4 mg/day)], 38.5% reported adverse events. The most common adverse events of special interest were neutropaenia and leukopaenia (7.7%), followed by serious infection (6.0%). The relapse-free proportion was 85.0%; relapse after remission, 6.0%; and no remission, 9.0%. At the last observation, 94.2% of relapse-free patients received a concomitant glucocorticoid dose of <10 mg/day. Fatigue, headache, neck pain, and absence of LVLs were positively associated with the relapse.

CONCLUSIONS

TCZ was effective and well tolerated in Japanese patients with GCA and may be an effective treatment option combined with glucocorticoids.

Для цитирования: Harigai Masayoshi, Miyamae Takako, Hashimoto Hideyuki, Umetsu Kosei, Yamashita Katsuhisa, Nakaoka Yoshikazu. A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan.. Modern rheumatology. 2024. DOI: 10.1093/mr/road074.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.